scholarly journals The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?

2018 ◽  
Vol 2018 ◽  
pp. 1-14 ◽  
Author(s):  
Ye-Shun Wu ◽  
Bin Zhu ◽  
Ai-Lin Luo ◽  
Ling Yang ◽  
Chun Yang
Keyword(s):  
Cardiovascular Disease ◽  
Heart Disease ◽  
Disease Burden ◽  
Heart Diseases ◽  
Critical Role ◽  
Physiological Role ◽  
Myocardial Damage ◽  
Promising Therapeutic Target ◽  
Potential Therapeutics

Cardiovascular disease remains the leading cause of morbidity and mortality, imposing a major disease burden worldwide. Therefore, there is an urgent need to identify new therapeutic targets. Recently, the concept that the heart acts as a secretory organ has attracted increasing attention. Proteins secreted by the heart are called cardiokines, and they play a critical physiological role in maintaining heart homeostasis or responding to myocardial damage and thereby influence the development of heart diseases. Given the critical role of cardiokines in heart disease, they might represent a promising therapeutic target. This review will focus on several cardiokines and discuss their roles in the pathogenesis of heart diseases and as potential therapeutics.

scholarly journals The Role of the Histone Methyltransferase EZH2 in Liver Inflammation and Fibrosis in STAM NASH Mice

Biology ◽  
2020 ◽  
Vol 9 (5) ◽  
pp. 93 ◽  
Author(s):  
Seul Lee ◽  
Dong-Cheol Woo ◽  
Jeeheon Kang ◽  
Moonjin Ra ◽  
Ki Hyun Kim ◽  
...  
Keyword(s):  
Liver Disease ◽  
Epigenetic Modification ◽  
Treatment Options ◽  
Histone Methyltransferase ◽  
Alcoholic Fatty Liver ◽  
Alcoholic Steatohepatitis ◽  
Promising Therapeutic Target ◽  
Alcoholic Fatty Liver Disease ◽  
Potential Therapeutics

Non-alcoholic fatty liver disease (NAFLD) is a leading form of chronic liver disease, with few biomarkers and treatment options currently available. Non-alcoholic steatohepatitis (NASH), a progressive disease of NAFLD, may lead to fibrosis, cirrhosis, and hepatocellular carcinoma. Epigenetic modification can contribute to the progression of NAFLD causing non-alcoholic steatohepatitis (NASH), in which the exact role of epigenetics remains poorly understood. To identify potential therapeutics for NASH, we tested small-molecule inhibitors of the epigenetic target histone methyltransferase EZH2, Tazemetostat (EPZ-6438), and UNC1999 in STAM NASH mice. The results demonstrate that treatment with EZH2 inhibitors decreased serum TNF-alpha in NASH. In this study, we investigated that inhibition of EZH2 reduced mRNA expression of inflammatory cytokines and fibrosis markers in NASH mice. In conclusion, these results suggest that EZH2 may present a promising therapeutic target in the treatment of NASH.

scholarly journals MicroRNAs in Cardiac Autophagy: Small Molecules and Big Role

Cells ◽  
2018 ◽  
Vol 7 (8) ◽  
pp. 104 ◽  
Author(s):  
Teng Sun ◽  
Meng-Yang Li ◽  
Pei-Feng Li ◽  
Ji-Min Cao
Keyword(s):  
Cardiac Fibrosis ◽  
Heart Diseases ◽  
Critical Role ◽  
Transcriptional Gene Silencing ◽  
Close Link ◽  
Post Transcriptional Gene Silencing ◽  
Evolutionarily Conserved ◽  
Cardiac Disorders ◽  
Cellular Components

Autophagy, which is an evolutionarily conserved process according to the lysosomal degradation of cellular components, plays a critical role in maintaining cell homeostasis. Autophagy and mitochondria autophagy (mitophagy) contribute to the preservation of cardiac homeostasis in physiological settings. However, impaired or excessive autophagy is related to a variety of diseases. Recently, a close link between autophagy and cardiac disorders, including myocardial infarction, cardiac hypertrophy, cardiomyopathy, cardiac fibrosis, and heart failure, has been demonstrated. MicroRNAs (miRNAs) are a class of small non-coding RNAs with a length of approximately 21–22 nucleotides (nt), which are distributed widely in viruses, plants, protists, and animals. They function in mediating the post-transcriptional gene silencing. A growing number of studies have demonstrated that miRNAs regulate cardiac autophagy by suppressing the expression of autophagy-related genes in a targeted manner, which are involved in the pathogenesis of heart diseases. This review summarizes the role of microRNAs in cardiac autophagy and related cardiac disorders. Furthermore, we mainly focused on the autophagy regulation pathways, which consisted of miRNAs and their targeted genes.

scholarly journals Role of TEE in Improving Diagnostic Accuracy of Congenital Heart Disease

2014 ◽  
Vol 2 (2) ◽  
pp. 68-70
Author(s):  
Sandeep Singh Rana ◽  
Balbir Kumar ◽  
Sethu Madhavan J
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Diagnostic Accuracy ◽  
Multimodal Imaging ◽  
Congenital Heart ◽  
Heart Diseases ◽  
Associated Lesions ◽  
Cardiac Lesions ◽  
Intraoperative Period

ABSTRACT Complex congenital heart diseases (CHD) often present as multiple cardiac lesions. The presence of one anomaly should stimulate the physician to perform a comprehensive assessment and look for other associated anomalies.1 Multimodal imaging may be necessary to diagnose such associated lesions as single imaging may occasionally miss them. Transthoracic echocardiography (TTE) and transesophageal echocardiography (TEE) are complimentary to each other. Routine use of TEE during intraoperative period may help us to refine diagnosis, detect the missing components and guide effective surgical repair. We present one such case where diagnosis and management were optimized by multimodal imaging. How to cite this article Kumar B, Madhavan JS, Puri GD, Rana SS. Role of TEE in Improving Diagnostic Accuracy of Congenital Heart Disease. J Perioper Echocardiogr 2014;2(2):68-70.

scholarly journals FTY720 Protects Cardiac Microvessels of Diabetes: A Critical Role of S1P1/3 in Diabetic Heart Disease

PLoS ONE ◽  
2012 ◽  
Vol 7 (8) ◽  
pp. e42900 ◽  
Author(s):  
Zhiyong Yin ◽  
Linni Fan ◽  
Liping Wei ◽  
Haokao Gao ◽  
Rongqing Zhang ◽  
...  
Keyword(s):  
Heart Disease ◽  
Critical Role ◽  
Diabetic Heart ◽  
Diabetic Heart Disease

HIV: cardiovascular disorders

2019 ◽  
pp. 589-594
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Heart Disease ◽  
Disease Risk ◽  
Heart Diseases ◽  
Hiv Treatment ◽  
Lifestyle Changes ◽  
Risk Profiling ◽  
Drug Treatments ◽  
Heart Disease Risk

This chapter discusses key cardiovascular conditions that effect people who live with HIV. HIV can lead to direct effect on the heart and the drug treatments may modify risk factors for heart disease. The chapter reviews the epidemiology of heart diseases in people who live with HIV . Specific disease processes are discussed, including cardiomyopathy, pericardial effusion, myocarditis, and endocarditis. Effect of HIV treatment on cardiovascular risk is discussed. Cardiovascular disease in people who live with HIV is reviewed with a focus on lifestyle changes, and effect of drugs on the heart and risk factors for heart disease. Risk profiling of cardiovascular disease is outlined with some discussion of treatment.

A LITERATURE REVIEW ON ANALYSIS OF PALM PATTERNS TO DETECT CONGENITAL HEART DISEASES

2020 ◽  
Vol 32 (02) ◽  
pp. 2050012
Author(s):  
Y. Mahesha ◽  
C. Nagaraju
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Heart Diseases ◽  
Congenital Heart Diseases ◽  
Normal People ◽  
Different Types ◽  
Left And Right ◽  
Paper Method

This paper presents the survey on different techniques which can be used to detect congenital heart disease using palm patterns. The congenital heart disease is one of the heart diseases which starts from birth. Research works are carried out towards detecting congenital heart disease before symptom appears using palm patterns so that it avoids critical health problems in future. Researchers have collected palm prints from normal people who are not suffering from any kind of heart disease and from patients who are suffering from different types of congenital heart diseases. These palm prints are collected from different hospitals. The palm prints are taken using ink and paper method. These palm patterns are analyzed to determine the role of palm pattern while detection of the disease. Few researchers have considered only triradius of palm and most of the researchers have considered palm patterns such as whorl, loop, arch and hypothenar pattern. In case of triradius, researchers have calculated position of axial triradius and it is categorized into three types. In case of whorl, loop and arch, they have considered how often they appear in palm of normal people and patients. Few researchers have analyzed both left and right hands of normal people and patients.

scholarly journals Diabetes, Heart Failure, and COVID-19: An Update

2021 ◽  
Vol 12 ◽  
Author(s):  
Carleigh Hebbard ◽  
Brooke Lee ◽  
Rajesh Katare ◽  
Venkata Naga Srikanth Garikipati
Keyword(s):  
Heart Failure ◽  
Cardiovascular Disease ◽  
Heart Disease ◽  
Disease Burden ◽  
Clinical Findings ◽  
Current Data ◽  
Future Research ◽  
The Novel ◽  
Research Areas ◽  
New Onset

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a pandemic by the WHO in March 2020. As of August 2021, more than 220 countries have been affected, accounting for 211,844,613 confirmed cases and 4,432,802 deaths worldwide. A new delta variant wave is sweeping through the globe. While previous reports consistently have demonstrated worse prognoses for patients with existing cardiovascular disease than for those without, new studies are showing a possible link between SARS-CoV-2 infection and an increased incidence of new-onset heart disease and diabetes, regardless of disease severity. If this trend is true, with hundreds of millions infected, the disease burden could portend a potentially troubling increase in heart disease and diabetes in the future. Focusing on heart failure in this review, we discuss the current data at the intersection of COVID, heart failure, and diabetes, from clinical findings to potential mechanisms of how SARS-CoV-2 infection could increase the incidence of those pathologies. Additionally, we posit questions for future research areas regarding the significance for patient care.

scholarly journals 394 Incidence and prevalence of acute myocarditis and pericarditis prior to and during COVID-19 pandemic

2021 ◽  
Vol 23 (Supplement_G) ◽  
Author(s):  
Roberto Licordari ◽  
Chrysanthos Grigoratos ◽  
Giancarlo Todiere ◽  
Andrea Barison ◽  
Antonio Micari ◽  
...  
Keyword(s):  
Heart Disease ◽  
Heart Diseases ◽  
Acute Myocarditis ◽  
Cardiac Injury ◽  
Annual Incidence ◽  
Time Intervals ◽  
Inflammatory Heart Disease ◽  
Heart Disorders ◽  
Areas Of Interest

Abstract Aims Myocarditis and pericarditis have been proposed to account for a proportion of cardiac injury during SARS-CoV-2 infection. During the COVID-19 pandemic, it is reasonable to expect an increasing trend in incidence of this acute inflammatory cardiac diseases. To examine the incidence and prevalence of inflammatory heart disorders prior to and during the COVID-19 pandemic. Methods and results This is a retrospective cohort study examining the incidence and prevalence of acute inflammatory heart diseases (myocarditis, pericarditis) in provinces of Pisa, Lucca and Livorno (total population of 11421285 inhabitants) in two time-intervals: (i) prior to (PRECOVID, from 1 June 2018 to 31 May 2019) and (ii) during the COVID-19 pandemic (COVID, from 1 June 2020 to May 2021). Overall 259 cases of inflammatory heart disease (myocarditis and/or pericarditis) occurred in the areas of interest. The annual incidence was of 11.3 cases per 100 000 inhabitants. Particularly, 138 cases occurred in the PRECOVID, and 121 in the COVID period. The annual incidence of inflammatory heart disease was not significantly different (12.1/100 000 in PRECOVID vs. 10.3/100 000 in COVID; P = 0.22). The annual incidence of acute myocarditis was significantly higher in PRECOVID than in the COVID: respectively, 8.1/100 000/year vs. 5.9/100 000 year (P = 0.047), consisting in a net reduction of 27% of cases. Particularly the incidence of myocarditis was significantly lower in COVID than in PRECOVID in the class of age 18–24 (P = 0.048) (Figure). The annual incidence of pericarditis was not significantly different (4.03/100 000 vs. 4.47/100 000; P = 0.61). Conclusions Despite a possible etiologic role of SARS-CoV-2 and an expectable increased incidence of myocarditis and pericarditis, data suggest a decrease of acute myocarditis and a stable incidence pericarditis and both diseases.

The growing landscape of succinylation links metabolism and heart disease

Epigenomics ◽  
2021 ◽  
Author(s):  
Lanting Yang ◽  
Shuo Miao ◽  
Jing Zhang ◽  
Peiyan Wang ◽  
Gaoli Liu ◽  
...  
Keyword(s):  
Heart Disease ◽  
Heart Diseases ◽  
Biochemical Process ◽  
Post Translational Modification ◽  
Functional Changes ◽  
Lysine Succinylation ◽  
Great Progress ◽  
Metabolic Reactions ◽  
Significant Chemical

Post-translational modification of proteins is an important biochemical process that occurs at the protein level. Succinylation is a newly discovered post-translational modification with the hallmark of a significant chemical and structural change. Succinylation has many similarities with other modifications, but succinylation may lead to more functional changes. Although the physiological significance of succinylation has not been well characterized, the lysine succinylation modification shows great potentials during disease processes. The discovery of SIRT5 has made great progress in exploring the role of succinylation in energy metabolism, heart disease and tumorigenesis. In this review, we focus on the discovery of succinylation in organisms and mechanism of succinylation. We are also concerned with the metabolic reactions and heart diseases associated with succinylation.

Abstract 243: Profilin-1 Phosphorylation Regulates Post-ischemic Cardiac Repair By Induction Of Vascular Stem Cell Homing

2014 ◽  
Vol 115 (suppl_1) ◽  
Author(s):  
Yi Fan
Keyword(s):  
Cell Migration ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Blood Vessels ◽  
De Novo ◽  
Critical Role ◽  
Cardiac Repair ◽  
Ischemic Heart ◽  
Endothelial Cell Migration

Neovascularization, the formation of new blood vessels, is fundamental to cardiac repair and regeneration in ischemic heart disease. After myocardial infarction (MI), vascular stem cells (VSC) are mobilized from bone marrow and recruited to the ischemic site, de novo generating new blood vessels to promote cardiac recovery. Our previous studies have revealed that phosphorylation of profilin-1 (Pfn-1) induces endothelial cell migration and sprouting angiogenesis. Here, we show that Pfn-1 phosphorylation regulates VSC homing to ischemic site and cardiac repair after MI through protease expression. Vascular lineage-specific knock-in of phosphorylation-dead Pfn-1(Y129F) mutant in mice show that Pfn-1 phosphorylation is critical for ischemia-induced neovascularization and cardiac function recovery after MI. Deficiency in Pfn-1 phosphorylation inhibits VSC homing to the ischemic hindlimb, suggesting a critical role of Pfn-1 phosphorylation in VSC recruitment. Mechanistic studies show that Pfn-1 phosphorylation is required for vascular endothelial growth factor (VEGF)-A-induced expression of metalloproteinase (MMP) −2 and −9 and cell migration in VSC. Therefore, these studies identify a critical role of Pfn-1 phosphorylation in VSC homing and neovascularization after MI, and suggest that Pfn-1 phosphorylation may represent as a therapeutic target for treating ischemic heart disease.

Sign in / Sign up

Export Citation Format

Share Document